Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Oct 15
 +2.55 / +1.47%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 217.00, with a high estimate of 254.00 and a low estimate of 183.00. The median estimate represents a +23.20% increase from the last price of 176.14.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.65%
Growthannually 13.30%


Growthquarterly 0.99%
Growthannually 22.19%
Key to the earnings and sales forecast charts.